FDA continues ban on silicone breast implants

In a surprise move, the FDA rejected an FDA expert advisory panel recommendation, and concluded that silicone gel breast implants should not be allowed back on the market for general use because there is insufficient data to indicate safety over the long term. The agency also published new, tougher guidelines for establishing the safety of the implants.

View Full Article in:

Washington Post (tiered subscription model), The · NYTimes.com · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health